ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. scores highest on Earnings (88) and lowest on Torque (54). Its PosiPenta is 64.05 out of 100, better than most similar companies.
On the Penta Grid this week, ANI Pharmaceuticals, Inc. is Grid #80 of 837 in the Healthcare sector in United States, and Grid #273 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. | 64.05 | 58 | 88 | 57 | 54 | 63 |
| Schrödinger, Inc. | 42.47 | 13 | 32 | 70 | 52 | 45 |
| Personalis, Inc. | 46.98 | 10 | 39 | 86 | 46 | 53 |
| Omnicell, Inc. | 61.03 | 48 | 85 | 59 | 62 | 51 |
| Kestra Medical Technologies, Ltd. | 44.73 | 9 | 32 | 91 | 36 | 56 |
| Healthcare Services Group, Inc. | 63.84 | 62 | 50 | 78 | 78 | 52 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 15.65 |
| P/B ratio | 2.78 |
EEarnings
| Trailing EPS | ₹437.58 |
| Forward EPS | ₹962.86 |
NNitro
| Price | 6846.94 |
| 52-week high | 9187.35 |
| 52-week low | 6590.27 |
| Fall from 52-week high | 25.5% |
TTorque
| Return on equity (ROE) | 20.46% |
| Debt-to-equity | 1.05 |
AAnchor
| Beta (price swings) | 0.49 |
| Market cap | ₹15,727 Cr |
| Insider holding | 5.42% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ANI Pharmaceuticals, Inc.'s PosiPenta score?
ANI Pharmaceuticals, Inc.'s PosiPenta is 64.05 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does ANI Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, ANI Pharmaceuticals, Inc. is Grid #80 of 837 in the Healthcare sector in United States, and Grid #273 of 4,000 in United States.
Which PosiPenta pillar is strongest for ANI Pharmaceuticals, Inc.?
Earnings (growth), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for ANI Pharmaceuticals, Inc.?
Torque (durability), with a score of 54 out of 100: around the middle of similar companies.
Has ANI Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 12.07 points, from 51.98 to 64.05.
PositoAI is for research and education only and is not investment advice.